Product Specifications

Key Features & Clinical Applications

• Standardized Mantoux Skin Testing: Indicated as a diagnostic aid to detect latent or active infection with Mycobacterium tuberculosis in adults and pediatric populations.

• Master-Batch Consistency: Formulated from a single master batch of tuberculin (PPD-S equivalent) to ensure standardized reactivity and eliminate batch-to-batch variation in induration reading.

• Polysorbate 80 Stabilized: Contains Tween-80 (Polysorbate 80) as a stabilizing agent to prevent adsorption of the protein derivative to glass vial surfaces and syringe walls.

• Flexible Clinic Packaging: Available in compact 1 mL (10-test) vials for low-volume clinics or high-capacity 5 mL (50-test) vials for high-volume occupational health screening, employee health departments, and public health facilities.

⚠️ Administration Requirement: Administer strictly via intradermal injection (Mantoux method) using a tuberculin syringe and 26- or 27-gauge needle. Do not administer subcutaneously or intravenously. Subcutaneous injection results in a false-negative or uninterpretable reading.

⚠️ Reading Window: The test must be read by a trained healthcare professional 48 to 72 hours post-administration by measuring the transverse diameter of induration (palpable swelling) in millimeters, not erythema.

⚠️ Contraindications: Contraindicated in patients with known hypersensitivity to tuberculin PPD, prior severe local reaction (e.g., necrosis, blistering, ulceration) to a tuberculin skin test, or documented active tuberculosis infection.